Eton Pharmaceuticals (ETON) Profit After Tax (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Profit After Tax data on file, last reported at $1.5 million in Q4 2025.

• For the quarter ending Q4 2025, Profit After Tax rose 347.99% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at -$4.6 million (down 20.35% YoY), and the FY2025 full-year result was -$4.6 million, down 20.35% from the prior year.
• Profit After Tax rose to $1.5 million in Q4 2025, from -$1.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $5.1 million in Q1 2021 to a low of -$6.1 million in Q3 2021.
• A 5-year average of -$1.0 million and a median of -$1.6 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax jumped 392.62% in 2023 and sank 407.34% in 2025, its largest moves.
• Tracing ETON's Profit After Tax over 5 years: stood at $1.0 million in 2021, then dropped by 12.22% to $912000.0 in 2022, then plunged by 347.37% to -$2.3 million in 2023, then surged by 73.49% to -$598000.0 in 2024, then soared by 347.99% to $1.5 million in 2025.
• Business Quant data shows ETON's Profit After Tax at $1.5 million in Q4 2025, -$1.9 million in Q3 2025, and -$2.6 million in Q2 2025.